Cigna Group Delivers Q3 Beat as 2027 Outlook Takes Shape, RBC Says

MT Newswires Live
Nov 19

Cigna Group's (CI) Q3 beat was driven by solid performance in Cigna Healthcare and continued momentum in Specialty and Care Services, RBC Capital Markets said in a note Wednesday.

Following the results, management expressed confidence in achieving at least 10% adjusted earnings per share growth from an about $30 base, adjusted for its exit from the Affordable Care Act, or ACA, exchange market, the analysts said.

The analysts said they are raising their 2026 adjusted EPS estimate to $30.66 from $30.49. However, they lowered their 2027 adjusted EPS estimate to $33.04 from $33.53.

The analysts added that this reduction mainly reflects stranded overhead costs from Cigna's ACA market exit and softer Evernorth margins due to smaller rebate pools and lower employer coverage of GLP-1 weight-loss drugs.

RBC raised its price target on Cigna to $346 from $337 while keeping its outperform rating.

Price: 271.94, Change: -13.44, Percent Change: -4.71

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10